Hightower 6M Holding’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$8.19M Sell
132,768
-2,393
-2% -$151K 0.74% 17
2022
Q2
$8.35M Sell
135,161
-1,823
-1% -$113K 0.7% 23
2022
Q1
$8.14M Buy
+136,984
New +$8.76M 0.62% 24

Other funds holding GILD

Hightower 6M Holding's GILD Position: Q3 2022 in Review

Hightower 6M Holding reduced its Gilead Sciences (GILD) stake by 1.8% in Q3 2022, selling an estimated $151K and leaving 132,768 shares worth $8.19M. The position accounts for 0.74% of the portfolio, ranked #17.

Hightower 6M Holding first reported a position in GILD in Q1 2022 and has held it in 3 quarters since. The position peaked at $8.35M in Q2 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Hightower 6M Holding held 132,768 shares of Gilead Sciences worth $8.19M as of Q3 2022.
  • Hightower 6M Holding sold 2,393 Gilead Sciences shares in Q3 2022, an estimated $151K.
  • Gilead Sciences made up 0.74% of Hightower 6M Holding's portfolio in Q3 2022, its #17 holding.
  • Hightower 6M Holding first reported a position in Gilead Sciences in Q1 2022 and has held it in 3 quarters since.
  • Hightower 6M Holding's Gilead Sciences position peaked at $8.35M in Q2 2022.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.